Stéphane De Wit

6.9k total citations · 2 hit papers
98 papers, 4.3k citations indexed

About

Stéphane De Wit is a scholar working on Emergency Medicine, Infectious Diseases and Epidemiology. According to data from OpenAlex, Stéphane De Wit has authored 98 papers receiving a total of 4.3k indexed citations (citations by other indexed papers that have themselves been cited), including 58 papers in Emergency Medicine, 42 papers in Infectious Diseases and 24 papers in Epidemiology. Recurrent topics in Stéphane De Wit's work include HIV-related health complications and treatments (57 papers), HIV/AIDS drug development and treatment (34 papers) and HIV/AIDS Research and Interventions (17 papers). Stéphane De Wit is often cited by papers focused on HIV-related health complications and treatments (57 papers), HIV/AIDS drug development and treatment (34 papers) and HIV/AIDS Research and Interventions (17 papers). Stéphane De Wit collaborates with scholars based in Belgium, United Kingdom and Denmark. Stéphane De Wit's co-authors include Jens Lundgren, Peter Reiss, Ole Kirk, Caroline Sabin, Andrew Phillips, Antonella d’Arminio Monforte, Wafaa El‐Sadr, Matthew Law, Rainer Weber and Nina Friis‐Møller and has published in prestigious journals such as The Lancet, PLoS ONE and Clinical Infectious Diseases.

In The Last Decade

Stéphane De Wit

94 papers receiving 4.2k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Trends in underlying causes of death in people with HIV from 1999 to 2011 (D:A:D): a multicohort collaboration

2014 689 citations Colette Smith, Lene Ryom et al. The Lancet profile →
Inflammation, Coagulation and Cardiovascular Disease in HIV-Infected Individuals

2012 419 citations Stéphane De Wit, Bruno Ledergerber et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Stéphane De Wit Belgium	31	3.0k	2.5k	1.4k	1.1k	578	98	4.3k
Jacqueline Neuhaus United States	24	2.8k 0.9×	2.2k 0.9×	1.9k 1.3×	981 0.9×	318 0.6×	38	4.2k
Stéphane De Wit Belgium	22	2.4k 0.8×	2.5k 1.0×	1.6k 1.1×	1.3k 1.2×	385 0.7×	66	4.2k
Nina Friis‐Møller Denmark	29	4.5k 1.5×	3.7k 1.5×	2.2k 1.5×	1.1k 1.0×	776 1.3×	57	5.9k
Lene Ryom Denmark	26	1.8k 0.6×	1.8k 0.7×	791 0.5×	855 0.8×	259 0.4×	74	2.9k
Daniel E. Nixon United States	18	2.0k 0.7×	1.6k 0.6×	1.7k 1.2×	1.0k 0.9×	220 0.4×	32	3.3k
Leonardo Calza Italy	30	1.4k 0.5×	1.6k 0.6×	882 0.6×	578 0.5×	412 0.7×	197	2.7k
Philippe Morlat France	33	1.5k 0.5×	2.1k 0.8×	1.0k 0.7×	1.8k 1.6×	237 0.4×	109	4.2k
P. Mercié France	31	1.2k 0.4×	1.4k 0.5×	889 0.6×	619 0.6×	225 0.4×	122	2.9k
Signe Westring Worm Denmark	20	2.2k 0.7×	1.7k 0.7×	1.1k 0.8×	498 0.4×	375 0.6×	34	2.8k
Fabrice Bonnet France	38	1.4k 0.5×	2.1k 0.8×	1.1k 0.8×	1.5k 1.4×	277 0.5×	173	4.4k

Countries citing papers authored by Stéphane De Wit

Since Specialization

Citations

This map shows the geographic impact of Stéphane De Wit's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Stéphane De Wit with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Stéphane De Wit more than expected).

Fields of papers citing papers by Stéphane De Wit

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Stéphane De Wit. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Stéphane De Wit. The network helps show where Stéphane De Wit may publish in the future.

Co-authorship network of co-authors of Stéphane De Wit

This figure shows the co-authorship network connecting the top 25 collaborators of Stéphane De Wit. A scholar is included among the top collaborators of Stéphane De Wit based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Stéphane De Wit. Stéphane De Wit is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Hatleberg, Camilla Ingrid, Lene Ryom, David A Kamara, et al.. (2019). Predictors of Ischemic and Hemorrhagic Strokes Among People Living With HIV: The D:A:D International Prospective Multicohort Study. EClinicalMedicine. 13. 91–100. 17 indexed citations

Ryom, Lene, Jens Lundgren, Matthew Law, et al.. (2019). Serious clinical events in HIV-positive persons with chronic kidney disease. AIDS. 33(14). 2173–2188. 9 indexed citations

Ryom, Lene, Wafaa El‐Sadr, Colette Smith, et al.. (2016). Improvements over time in short-term mortality following myocardial infarction in HIV-positive individuals. AIDS. 30(10). 1583–1596. 9 indexed citations

Ryom, Lene, Jens Lundgren, Stéphane De Wit, et al.. (2016). Use of antiretroviral therapy and risk of end-stage liver disease and hepatocellular carcinoma in HIV-positive persons. AIDS. 30(11). 1731–1743. 45 indexed citations

Sabin, Caroline, Peter Reiss, Lene Ryom, et al.. (2016). Is there continued evidence for an association between abacavir usage and myocardial infarction risk in individuals with HIV? A cohort collaboration. BMC Medicine. 14(1). 61–61. 91 indexed citations

Shahmanesh, Maryam, Anna Schultze, Fiona Burns, et al.. (2016). The cardiovascular risk management for people living with HIV in Europe. AIDS. 30(16). 2505–2518. 23 indexed citations

Dauby, Nicolás, et al.. (2015). Acute myocardial infarction following thalidomide treatment for AIDS-related ulcers. AIDS. 29(9). 1119–1120.

Smith, Colette, Lene Ryom, Rainer Weber, et al.. (2014). Trends in underlying causes of death in people with HIV from 1999 to 2011 (D:A:D): a multicohort collaboration. The Lancet. 384(9939). 241–248. 689 indexed citations breakdown →

Shepherd, Leah, Álvaro H. Borges, Richard J. Harvey, et al.. (2014). Predictive value of prostate‐specific antigen for prostate cancer: a nested case‐control study in EuroSIDA. Journal of the International AIDS Society. 17(4S3). 19510–19510. 1 indexed citations

10.

Konopnicki, Déborah, Yannick Manigart, Christine Gilles, et al.. (2013). Sustained Viral Suppression and Higher CD4+ T-Cell Count Reduces the Risk of Persistent Cervical High-Risk Human Papillomavirus Infection in HIV-Positive Women. The Journal of Infectious Diseases. 207(11). 1723–1729. 61 indexed citations

11.

Worm, Signe Westring, Mark Bower, Peter Reiss, et al.. (2013). Non-AIDS defining cancers in the D:A:D Study - time trends and predictors of survival: a cohort study. BMC Infectious Diseases. 13(1). 471–471. 58 indexed citations

12.

Sabin, Caroline, Lene Ryom, Helen Kovari, et al.. (2013). Association Between ALT Level and the Rate of Cardio/Cerebrovascular Events in HIV-Positive Individuals. JAIDS Journal of Acquired Immune Deficiency Syndromes. 63(4). 456–463. 11 indexed citations

13.

Sabin, Caroline, Lene Ryom, Stéphane De Wit, et al.. (2013). Associations between immune depression and cardiovascular events in HIV infection. AIDS. 27(17). 2735–2748. 48 indexed citations

14.

Wyndham-Thomas, Chloé, et al.. (2013). BARRIERS TO LIVER TRANSPLANTATION IN HIV INFECTED PATIENTS. Acta Clinica Belgica. 68(5). 349–355.

15.

Petoumenos, Kathy, Signe Westring Worm, Éric Fontas, et al.. (2012). Predicting the short‐term risk of diabetes in HIV‐positive patients: the Data Collection on Adverse Events of Anti‐HIV Drugs (D:A:D) study. Journal of the International AIDS Society. 15(2). 17426–17426. 53 indexed citations

16.

Smit, Colette, Jonathan A C Sterne, Antonella d’Arminio Monforte, et al.. (2012). Effect of Hepatitis C Treatment on Cd4⁺ T-C El L Counts And The Risk Of Death In HIV–HCV-Coinfected Patients: The Cohere Collaboration. Antiviral Therapy. 17(8). 1541–1550. 7 indexed citations

17.

Friis‐Møller, Nina, Rodolphe Thiébaut, Peter Reiss, et al.. (2010). Predicting the risk of cardiovascular disease in HIV-infected patients: the Data collection on Adverse Effects of Anti-HIV Drugs Study. European Journal of Cardiovascular Prevention & Rehabilitation. 17(5). 491–501. 283 indexed citations

18.

Fontas, Éric, Frank van Leth, Caroline Sabin, et al.. (2004). Lipid Profiles in HIV‐Infected Patients Receiving Combination Antiretroviral Therapy: Are Different Antiretroviral Drugs Associated with Different Lipid Profiles?. The Journal of Infectious Diseases. 189(6). 1056–1074. 274 indexed citations

19.

Baily, Guy, et al.. (1997). Candida inconspicua, a Fluconazole‐Resistant Pathogen in Patients Infected with Human Immunodeficiency Virus. Clinical Infectious Diseases. 25(1). 161–163. 27 indexed citations

20.

Snoeck, Robert, Stéphane De Wit, Camélia Rossi, et al.. (1996). Treatment of progressive multifocal leukoencephalopathy (PLM) with Cidofovir in an AIDS patient. Antiviral Research. 30(1). 51. 5 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact